EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Myasthenic crisis

Benjamin Claytor, Sung-Min Cho, Yuebing Li iD

Muscle & Nerve · 2023-07 · 68 (1) · 8-19

DOI: 10.1002/mus.27832 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Muscle & Nerve, online erschienen am 28.04.2023. Verfasst von Benjamin Claytor und 2 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular Center, Department of Neurology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Myasthenia Gravis, Thymus Neoplasms. Die Arbeit wurde bisher 146-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myasthenic crisis (MC) is a life‐threatening manifestation of myasthenia gravis (MG) defined by respiratory insufficiency that requires the use of invasive or non‐invasive ventilation. This is often the result of respiratory muscle weakness but can also be due to bulbar weakness with upper airway collapse. MC occurs in approximately 15%–20% of patients with MG usually within the first 2 to 3 y of the disease course. Many crises have a specific trigger with respiratory infections being most common; however, no specific trigger is found in 30%–40% of patients. MG patients with a history of MC, severe disease, oropharyngeal weakness, muscle‐specific kinase (MuSK) antibodies and thymoma appear to be at higher risk. Most episodes of MC do not occur suddenly, providing a window of opportunity for prevention. Immediate treatment is directed toward airway management and removing any identified triggers. Plasmapheresis is preferred over intravenous immune globulin as the treatments of choice for MC. The majority of patients are able to be weaned from mechanical ventilation within 1 mo and the outcomes of MC are generally favorable. The mortality rate in United States cohorts is less than 5% and mortality in MC seems to be driven by age and other medical co‐morbidities. MC does not appear to affect long‐term prognosis as many patients are able to eventually achieve good MG control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisThymus NeoplasmsHumansMuscle WeaknessPlasmapheresisRespiration, Artificial

Stichwörter der Autor:innen

mechanical ventilationmyasthenia gravismyasthenic crisisplasmapheresis

Autor:innen und Institutionen

  • Neuromuscular Center, Department of Neurology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Division of Neuroscience Critical Care, Departments of Neurology, Neurosurgery, Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Yuebing Li

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Claytor, B., Cho, S. M., & Li, Y. (2023). Myasthenic crisis. Muscle & Nerve, 68(1), 8-19. https://doi.org/10.1002/mus.27832

Vancouver

Claytor B, Cho SM, Li Y. Myasthenic crisis. Muscle & Nerve. 2023;68(1):8-19. doi:10.1002/mus.27832

BibTeX
@article{Claytor2023,
  author = {Claytor, Benjamin and Cho, Sung-Min and Li, Yuebing},
  title = {Myasthenic crisis},
  journal = {Muscle & Nerve},
  year = {2023},
  volume = {68},
  number = {1},
  pages = {8--19},
  doi = {10.1002/mus.27832}
}
Kostenlos starten →